First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    Oncolytics Biotech Inc.

    ONCY · 3 developments mapped · last assessed 2026-09-29

    Market Ontology has mapped 3 macro, policy, and market developments to Oncolytics Biotech Inc. since 2026-09-29. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for ONCY yet, so no modelled value is shown. The ONCY valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run ONCY on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for ONCY. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Strongest support

      Oncolytics Biotech Announces Publication of Pelareorep Data in Liver Cancer

      Positive clinical data publication enhancing drug candidate's profile and market perception, potentially attracting partnerships or investment.

      · Moves probability of success for pelareorep in liver cancer, peak sales potential for pelareorep, discount rate reflecting reduced clinical risk

    What changed, by assumption

    Probability of success for pelareorep in liver cancer
    • 2026-09-29Oncolytics Biotech Announces Publication of Pelareorep Data in Liver Cancer
    • 2026-09-29Oncolytics Biotech Inc. Announces Publication of Pelareorep Data in Liver Cancer
    Probability of success (pos) for pelareorep in liver cancer
    • 2026-09-29Oncolytics Biotech Inc Announces Publication of Pelareorep Liver Cancer Data

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-29Oncolytics Biotech Inc. Announces Publication of Pelareorep Data in Liver CancerBullish1-3m0.70
    2026-09-29Oncolytics Biotech Announces Publication of Pelareorep Data in Liver CancerBullish1-3m0.80
    2026-09-29Oncolytics Biotech Inc Announces Publication of Pelareorep Liver Cancer DataBullish1-3m0.80